MicroRNA Profiling of Chinese Primary Glioblastoma Reveals a Temozolomide-Chemoresistant Subtype

Oncotarget - United States
doi 10.18632/oncotarget.3258
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide

Cancers
Cancer ResearchOncology
2019English

Temozolomide Nanoparticles for Targeted Glioblastoma Therapy

ACS Applied Materials & Interfaces
MedicineMaterials ScienceNanotechnologyNanoscience
2015English

MicroRNA Profiling Reveals Distinct Signatures in Degenerative Rotator Cuff Pathologies

Journal of Orthopaedic Research
OrthopedicsSports Medicine
2019English

Differential Localization of Glioblastoma Subtype: Implications on Glioblastoma Pathogenesis

Oncotarget
Oncology
2016English

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

Neurologia Medico-Chirurgica
SurgeryNeurology
2018English

The Prolonged Use of Temozolomide in Glioblastoma Patients

JBNC - JORNAL BRASILEIRO DE NEUROCIRURGIA
2018English

Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D

Frontiers in Pharmacology
Pharmacology
2019English

Metabolic Targeting of EGFRvIII/PDK1 Axis in Temozolomide Resistant Glioblastoma

Oncotarget
Oncology
2017English

Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy